Invivyd (IVVD) Research & Development (2021 - 2026)

Invivyd (IVVD) has reported Research & Development for 6 consecutive years, with $29.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 206.77% year-over-year to $29.4 million; the trailing twelve-month figure through Jun 2026 stood at $57.0 million (down 40.57% YoY), and the FY2025 full-year result was $38.3 million, down 72.09% from the prior year.
• Research & Development improved to $29.4 million in Q2 2026 per IVVD's latest filing, from $10.0 million in the prior quarter.
• Across five years, Research & Development topped out at $92.0 million in Q1 2022 and bottomed at $8.0 million in Q3 2025.
• Historically, Research & Development has averaged $31.9 million across 5 years, with a median of $29.4 million in 2026.
• The sharpest annual moves came in 2023 and 2025: Research & Development soared 212.59% in 2023, then sank 86.09% in 2025.
• Over 5 years, Research & Development stood at $19.9 million in 2022, then jumped by 212.59% to $62.3 million in 2023, then tumbled by 71.24% to $17.9 million in 2024, then plunged by 43.9% to $10.0 million in 2025, then soared by 192.27% to $29.4 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $29.4 million, $10.0 million, and $8.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.